This client was considering acquisition of a company with a critical reagent used in the manufacture of viral vectors. To understand the market opportunity, DHC was asked to estimate current and future market sizes for this material as it pertained to its use in Adeno-Associated Virus (AAV) and Lentiviral Vector (LVV) manufacturing processes. This market size assessment was one piece of a broader diligence project conducted for this client. (Find an example of a full diligence case study here.)
In addition to providing comprehensive diligence support, DHC provided a detailed overview of market size for the reagent in question to build a better understanding of whether this potential opportunity aligned with the client’s investment thesis. The analysis performed provided the necessary details—including a consideration of the magnitude of potentially obtainable market share for this target—to allow the client to make a solid data-driven decision on future investments.